Developer docs
API playgroundTry for free, no card

Search company profiles

Orthopy Health

Full company profile

uuid000ia2a

Namestring
Orthopy Health
Legal namestring
Orthopy Health GmbH
Websiteurl
orthopy.de
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Orthopy Health GmbH is a Hamburg-based digital health company founded in October 2020 that develops the Orthopy App, a CE-marked Class I medical device under EU MDR 2017/745, delivering digital therapy accompaniment for patients recovering from knee injuries (ACL ruptures, meniscus injuries, and ankle distortions). The mobile application provides personalized training programs derived from physician-prescribed parameters (diagnosis, treatment phase, movement range, load specifications), video/audio/text-guided exercises, a prehabilitation module for pre-surgical preparation, symptom and progress logging, push-notification reminders, and FHIR/MIO-compliant data export. Educational content is delivered through the Orthopedia knowledge base integrated into the app ecosystem.

The company's commercial model is currently transitional: the primary access route is free participation in the Versorgungsbeobachtung (observational study) program, with secondary self-pay purchase and a Rezeptservice that supports private health insurance reimbursement submissions. Orthopy is not currently listed in the DiGA directory and therefore cannot be reimbursed by statutory health insurance. Go-to-market combines a sales-led motion (physicians and physiotherapists prescribing or recommending the app via the Fachkreise portal) with self-serve patient downloads on iOS and Android, supported by content marketing, clinical study publications, and social media.

As of 2025, Orthopy supports over 11,000 patients with a team of 20+ employees and operates from Hamburg (headquarters and Health Innovation Port). The company holds ISO 13485, ISO 27001, ISO 27017, ISO 27018, GDPR, BSI TR-03161, and DiGAV-aligned compliance certifications. In 2025, Orthopy entered an exclusive strategic partnership with Enovis, a global orthopedic medical technology company, to scale distribution and integrate the app into Enovis's product portfolio, while concurrently conducting the AMORE randomized controlled trial across 8 German study centers to build DiGA-grade clinical evidence.

Short descriptiontext

Orthopy Health is a Hamburg-based digital therapeutics company that operates the Orthopy App, a CE-marked Class I medical device providing personalized rehabilitation programs, exercise guidance, and education for patients recovering from knee injuries such as ACL ruptures and meniscus damage.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHamburg, Germany
HQ citystring
Hamburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital therapeutics, orthopedic rehabilitation, mobile health applications, medical device software, digital health applications
Industry4 codes
PRIMARYHLALAGAO
Orthopedics & Sports Medicine Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
SECONDARYHLACANAE
SaMD – Monitoring, Triage & Risk Stratification Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code3 codes
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
  • Offices of Other Health Practitioners6213
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists621340
SIC code3 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Services-Prepackaged Software7372
  • Surgical & Medical Instruments & Apparatus3841
Product category
Digital Therapeutics — Orthopedic Rehabilitation Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Versorgungsbeobachtung (Observational Study)
TypeSubscription Recurring
Description

Currently the primary access model. Patients participate in a voluntary observational study, receiving the app free of charge. The study collects health outcomes data to evaluate the app's effectiveness and support future regulatory and reimbursement pathways.

orthopy.de
2Private Health Insurance Reimbursement
TypeSubscription Recurring
Description

Private health insurance patients can submit receipts for potential reimbursement through the Rezeptservice. The company facilitates submission but does not guarantee reimbursement.

orthopy.de
3Direct Self-Pay Purchase
TypeOne Time License
Description

Patients can purchase the app directly as self-payers. A purchase agreement is formed upon payment, with a personal, non-transferable right to use the app for the specified duration.

orthopy.de
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Versorgungsbeobachtung - Free access for study participants
ModelFreemiumBilling cadenceAnnual
Notes

Patients receive free access by participating in the voluntary observational study. Access valid for at least 12 months. Data deleted if app not used for 3 consecutive months after 12-month period.

orthopy.de
2Direct Purchase - Self-pay option
ModelSubscriptionBilling cadenceAnnual
Notes

Self-payers can purchase access. Price not publicly disclosed on website. Contact required for quote.

orthopy.de
GTM typeB2C
B2C
Offering typeSoftware
Software
Core offering1 text field

Orthopy Health sells the Orthopy App, a CE-marked Class I medical device mobile application (iOS and Android) that delivers personalized, evidence-based digital therapy accompaniment for patients with knee injuries including ACL ruptures, meniscus damage, and ankle distortions. The app provides individualized training programs with video/audio-guided exercises, prehabilitation modules, patient education content, progress tracking, symptom logging, and interoperable data export for healthcare providers. Patients access the app primarily through the Versorgungsbeobachtung observational study (free), private health insurance reimbursement, or direct self-pay purchase.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Statistically significant pain reduction (p=0.0005 at t1, p=0.0068 at t2, p=0.01 at t4)
+3 more records
Product overview1 text field

Orthopy Health offers the Orthopy App as its primary core product — a certified digital therapeutic (Class I medical device under MDR) designed for patients with knee injuries. The app provides individualized physiotherapy training programs, guided exercise videos, patient education content, and progress tracking. The portfolio includes Orthopedia, a knowledge platform with educational articles about injuries and recovery. The company also conducts clinical research through the AMORE study to validate the app's effectiveness for ACL and meniscus injuries. The app is available as a mobile application for iOS and Android, with interoperability support for FHIR/MIO data export standards.

Product and service2 records
1Orthopy App
CategoryDigital Therapeutics / Medical Device Software
Description

A CE-marked Class I medical device mobile app (iOS and Android) that delivers individualized digital therapy for patients with knee injuries (ACL ruptures, meniscus damage, ankle distortions). Provides personalized training programs, prehabilitation modules, video/audio-guided exercises, patient education, progress tracking, symptom logging, and FHIR/MIO-compliant data export. Distributed through app stores, observational study enrollment, private insurance reimbursement, and self-pay.

2Orthopedia
CategoryPatient Education Content Platform
Description

A knowledge hub providing educational articles about knee anatomy, injury types (ACL, meniscus), treatment options, recovery processes, and self-care techniques, integrated within the Orthopy App and website ecosystem for patient education.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Enovis, a global leader in orthopedics and medical technology, is the exclusive partner of Orthopy Health GmbH. For Enovis, this partnership represents an expansion of their product portfolio and a deliberate step to integrate digital innovations into their healthcare offerings, sustainably improving patient care.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Ormed GmbH (Bötzlinger Straße 90, 79111 Freiburg) is a specialized service provider engaged by Orthopy for the administrative processing of DiGA prescriptions and customer support. A strict data processing agreement (Auftragsverarbeitung) is in place.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical study center for AMORE clinical trial investigating digital therapy for ACL and meniscus injuries. Located in Pforzheim, Germany. Study led by Dr. Christian Sobau.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical study center for AMORE clinical trial. Located in Freiburg, Germany. Study led by Prof. Dr. Gerrit Bode.

5ACOS-Praxisklinik (Heilbronn)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical study center conducting the meniscus study only. Located in Heilbronn, Germany. Study led by Dr. Oliver Eckardt.

orthopy.de
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical study center for AMORE clinical trial. Located in Stuttgart, Germany. Study led by Dr. Nikolas Kolbe.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical study center for AMORE clinical trial. Located in Erlangen, Germany. Study led by Prof. Dr. Thomas Tischer and Dr. Alvaro Gallardo.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical study center for AMORE clinical trial. Located in Pfronten, Germany. Study led by Dr. Björn Drews.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical study center for AMORE clinical trial. Located in Zwickau, Germany. Study led by Dr. Franziska Kupferschmied.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical study center for AMORE clinical trial. Located in Großhansdorf, Germany. Study led by Dr. Matthias Gebhardt.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Kaia Health offers app-based digital therapeutic programs for musculoskeletal pain, including back pain and knee/hip conditions. Comparable to Orthopy in offering personalized exercise therapy via mobile app with a clinical evidence base, though it operates across multiple indications and geographies.

TypeDirect peer
Description

Caspar Health provides digital rehabilitation platforms connecting patients with therapists for post-surgical and orthopedic rehabilitation, available in Germany and other European markets. Comparable to Orthopy in targeting orthopedic rehabilitation through digital channels, with a hybrid human-plus-digital model.

TypeBroad incumbent
Description

Enovis is a global medical technology company specializing in orthopedic implants, surgical equipment, and recovery products, and is Orthopy's exclusive strategic partner. Enovis is comparable as an incumbent orthopedic player integrating digital health capabilities, and its partnership with Orthopy creates a channel and validation anchor that no other peer has at this scale.

TypeDirect peer
Description

Vivira is a German DiGA-listed digital therapeutic for back pain, offering prescribed app-based exercise therapy with physician monitoring. Directly comparable to Orthopy as a German musculoskeletal digital therapeutic pursuing the same DiGA prescription pathway and patient demographic.

TypeBroad incumbent
Description

Omada Health is a US digital chronic care company offering virtual care programs for diabetes, hypertension, and musculoskeletal conditions. Comparable to Orthopy as a regulated digital therapeutic with clinical evidence, though broader in scope and more commercially mature.

TypeDirect peer
Description

Selfapy is a German digital health company offering DiGA-listed courses for conditions including back pain, depression, and insomnia. Comparable to Orthopy as a German-language digital therapeutic pursuing the same DiGA reimbursement pathway, though focused on different indications.

7Re.flex
TypeEmerging player
Description

Re.flex offers a digital MSK solution combining motion-tracking sensors with a smartphone app for knee and hip rehabilitation. Comparable to Orthopy in targeting knee rehabilitation via mobile app, with a distinguishing motion-sensor hardware component.

TypeBroad incumbent
Description

Hinge Health is one of the largest digital MSK platforms globally, offering app-based exercise therapy, coaching, and wearable sensors for back, knee, hip, and other joint conditions. While US-focused and broader in scope than Orthopy's knee-only focus, it represents the scaled incumbent model of digital orthopedic therapy that Orthopy aspires to in Europe.

TypeBroad incumbent
Description

medi is a German medical device manufacturer with significant orthopedic braces, supports, and compression products. As an established German orthopedic medical device incumbent with direct surgeon relationships, medi represents a potential competitive or partnership counterpart to Orthopy in the orthopedic care pathway.

10Sword Health
TypeDirect peer
Description

Sword Health is a digital MSK care provider offering virtual physical therapy with AI-guided exercise programs. Comparable to Orthopy in targeting musculoskeletal rehabilitation through digital tools, with a broader scope including back, hip, knee, and pelvic conditions, and a stronger commercial presence in the US and EU employer/payer market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Orthopy Health

Digital Therapeutics — Orthopedic Rehabilitation Softwareorthopy.de

Orthopy Health is a Hamburg-based digital therapeutics company that operates the Orthopy App, a CE-marked Class I medical device providing personalized rehabilitation programs, exercise guidance, and education for patients recovering from knee injuries such as ACL ruptures and meniscus damage.

What Orthopy Health does

Orthopy Health GmbH is a Hamburg-based digital health company founded in October 2020 that develops the Orthopy App, a CE-marked Class I medical device under EU MDR 2017/745, delivering digital therapy accompaniment for patients recovering from knee injuries (ACL ruptures, meniscus injuries, and ankle distortions). The mobile application provides personalized training programs derived from physician-prescribed parameters (diagnosis, treatment phase, movement range, load specifications), video/audio/text-guided exercises, a prehabilitation module for pre-surgical preparation, symptom and progress logging, push-notification reminders, and FHIR/MIO-compliant data export. Educational content is delivered through the Orthopedia knowledge base integrated into the app ecosystem.

The company's commercial model is currently transitional: the primary access route is free participation in the Versorgungsbeobachtung (observational study) program, with secondary self-pay purchase and a Rezeptservice that supports private health insurance reimbursement submissions. Orthopy is not currently listed in the DiGA directory and therefore cannot be reimbursed by statutory health insurance. Go-to-market combines a sales-led motion (physicians and physiotherapists prescribing or recommending the app via the Fachkreise portal) with self-serve patient downloads on iOS and Android, supported by content marketing, clinical study publications, and social media.

As of 2025, Orthopy supports over 11,000 patients with a team of 20+ employees and operates from Hamburg (headquarters and Health Innovation Port). The company holds ISO 13485, ISO 27001, ISO 27017, ISO 27018, GDPR, BSI TR-03161, and DiGAV-aligned compliance certifications. In 2025, Orthopy entered an exclusive strategic partnership with Enovis, a global orthopedic medical technology company, to scale distribution and integrate the app into Enovis's product portfolio, while concurrently conducting the AMORE randomized controlled trial across 8 German study centers to build DiGA-grade clinical evidence.

Orthopy Health firmographics

Firmographics
Name
Orthopy Health
Legal name
Orthopy Health GmbH
Website
https://orthopy.de
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Orthopy Health is a Hamburg-based digital therapeutics company that operates the Orthopy App, a CE-marked Class I medical device providing personalized rehabilitation programs, exercise guidance, and education for patients recovering from knee injuries such as ACL ruptures and meniscus damage.
Ownership category
akta.pro rank

Orthopy Health industry classification

Industry
Product category
Digital Therapeutics — Orthopedic Rehabilitation Software
NAICS
Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Offices of Other Health Practitioners (6213), Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLALAGAO
Orthopedics & Sports Medicine Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
SECONDARYHLACANAE
SaMD – Monitoring, Triage & Risk Stratification Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Digital therapeutics
  • Orthopedic rehabilitation
  • Mobile health applications
  • Medical device software
  • Digital health applications

Where Orthopy Health is headquartered

Location

Headquarters

HQ city
Hamburg
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Orthopy Health business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Versorgungsbeobachtung (Observational Study): Currently the primary access model. Patients participate in a voluntary observational study, receiving the app free of charge. The study collects health outcomes data to evaluate the app's effectiveness and support future regulatory and reimbursement pathways.
  2. Private Health Insurance Reimbursement: Private health insurance patients can submit receipts for potential reimbursement through the Rezeptservice. The company facilitates submission but does not guarantee reimbursement.
  3. Direct Self-Pay Purchase: Patients can purchase the app directly as self-payers. A purchase agreement is formed upon payment, with a personal, non-transferable right to use the app for the specified duration.

Pricing tiers

ModelBillingPrice
FreemiumAnnualVersorgungsbeobachtung - Free access for study participants
SubscriptionAnnualDirect Purchase - Self-pay option

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Orthopy Health product offering

Product offering

Core offering

Orthopy Health sells the Orthopy App, a CE-marked Class I medical device mobile application (iOS and Android) that delivers personalized, evidence-based digital therapy accompaniment for patients with knee injuries including ACL ruptures, meniscus damage, and ankle distortions. The app provides individualized training programs with video/audio-guided exercises, prehabilitation modules, patient education content, progress tracking, symptom logging, and interoperable data export for healthcare providers. Patients access the app primarily through the Versorgungsbeobachtung observational study (free), private health insurance reimbursement, or direct self-pay purchase.

Product overview

Orthopy Health offers the Orthopy App as its primary core product — a certified digital therapeutic (Class I medical device under MDR) designed for patients with knee injuries. The app provides individualized physiotherapy training programs, guided exercise videos, patient education content, and progress tracking. The portfolio includes Orthopedia, a knowledge platform with educational articles about injuries and recovery. The company also conducts clinical research through the AMORE study to validate the app's effectiveness for ACL and meniscus injuries. The app is available as a mobile application for iOS and Android, with interoperability support for FHIR/MIO data export standards.

Differentiator

Problem solved

Functional benefit

Products and services

  • Orthopy App A CE-marked Class I medical device mobile app (iOS and Android) that delivers individualized digital therapy for patients with knee injuries (ACL ruptures, meniscus damage, ankle distortions). Provides personalized training programs, prehabilitation modules, video/audio-guided exercises, patient education, progress tracking, symptom logging, and FHIR/MIO-compliant data export. Distributed through app stores, observational study enrollment, private insurance reimbursement, and self-pay.
  • Orthopedia A knowledge hub providing educational articles about knee anatomy, injury types (ACL, meniscus), treatment options, recovery processes, and self-care techniques, integrated within the Orthopy App and website ecosystem for patient education.

Quantifiable outcome

  • Statistically significant pain reduction (p=0.0005 at t1, p=0.0068 at t2, p=0.01 at t4)
  • +3 more outcomes

Companies that use Orthopy Health

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Orthopy Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Orthopy Health partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • EnoviscoreStrategic or Co-development PartnerEnovis, a global leader in orthopedics and medical technology, is the exclusive partner of Orthopy Health GmbH. For Enovis, this partnership represents an expansion of their product portfolio and a deliberate step to integrate digital innovations into their healthcare offerings, sustainably improving patient care.
  • Ormed GmbHminorImplementation/ SI/ Consulting PartnerOrmed GmbH (Bötzlinger Straße 90, 79111 Freiburg) is a specialized service provider engaged by Orthopy for the administrative processing of DiGA prescriptions and customer support. A strict data processing agreement (Auftragsverarbeitung) is in place.
  • ARCUS KlinikencoreStrategic or Co-development PartnerClinical study center for AMORE clinical trial investigating digital therapy for ACL and meniscus injuries. Located in Pforzheim, Germany. Study led by Dr. Christian Sobau.
  • Praxisklinik 2000 (Freiburg)coreStrategic or Co-development PartnerClinical study center for AMORE clinical trial. Located in Freiburg, Germany. Study led by Prof. Dr. Gerrit Bode.
  • ACOS-Praxisklinik (Heilbronn)minorStrategic or Co-development PartnerClinical study center conducting the meniscus study only. Located in Heilbronn, Germany. Study led by Dr. Oliver Eckardt.
  • Orthopädische Klinik Stuttgart-BotnangminorStrategic or Co-development PartnerClinical study center for AMORE clinical trial. Located in Stuttgart, Germany. Study led by Dr. Nikolas Kolbe.
  • Malteser Waldkrankenhaus (Erlangen)minorStrategic or Co-development PartnerClinical study center for AMORE clinical trial. Located in Erlangen, Germany. Study led by Prof. Dr. Thomas Tischer and Dr. Alvaro Gallardo.
  • St. Vinzenz Allgäu (Pfronten)minorStrategic or Co-development PartnerClinical study center for AMORE clinical trial. Located in Pfronten, Germany. Study led by Dr. Björn Drews.
  • Heinrich-Braun-Klinikum (Zwickau)minorStrategic or Co-development PartnerClinical study center for AMORE clinical trial. Located in Zwickau, Germany. Study led by Dr. Franziska Kupferschmied.
  • Klinik Manhagen (Großhansdorf)minorStrategic or Co-development PartnerClinical study center for AMORE clinical trial. Located in Großhansdorf, Germany. Study led by Dr. Matthias Gebhardt.

Scale indicators3 records

Recent moves10 records

Expansion highlights6 records

Orthopy Health competitors and assessment

Company assessment

Direct peers

  • Kaia Health: Kaia Health offers app-based digital therapeutic programs for musculoskeletal pain, including back pain and knee/hip conditions. Comparable to Orthopy in offering personalized exercise therapy via mobile app with a clinical evidence base, though it operates across multiple indications and geographies.
  • Caspar Health: Caspar Health provides digital rehabilitation platforms connecting patients with therapists for post-surgical and orthopedic rehabilitation, available in Germany and other European markets. Comparable to Orthopy in targeting orthopedic rehabilitation through digital channels, with a hybrid human-plus-digital model.
  • Vivira Health Lab: Vivira is a German DiGA-listed digital therapeutic for back pain, offering prescribed app-based exercise therapy with physician monitoring. Directly comparable to Orthopy as a German musculoskeletal digital therapeutic pursuing the same DiGA prescription pathway and patient demographic.
  • Selfapy: Selfapy is a German digital health company offering DiGA-listed courses for conditions including back pain, depression, and insomnia. Comparable to Orthopy as a German-language digital therapeutic pursuing the same DiGA reimbursement pathway, though focused on different indications.
  • Sword Health: Sword Health is a digital MSK care provider offering virtual physical therapy with AI-guided exercise programs. Comparable to Orthopy in targeting musculoskeletal rehabilitation through digital tools, with a broader scope including back, hip, knee, and pelvic conditions, and a stronger commercial presence in the US and EU employer/payer market.

Broad incumbents

  • Enovis: Enovis is a global medical technology company specializing in orthopedic implants, surgical equipment, and recovery products, and is Orthopy's exclusive strategic partner. Enovis is comparable as an incumbent orthopedic player integrating digital health capabilities, and its partnership with Orthopy creates a channel and validation anchor that no other peer has at this scale.
  • Omada Health: Omada Health is a US digital chronic care company offering virtual care programs for diabetes, hypertension, and musculoskeletal conditions. Comparable to Orthopy as a regulated digital therapeutic with clinical evidence, though broader in scope and more commercially mature.
  • Hinge Health: Hinge Health is one of the largest digital MSK platforms globally, offering app-based exercise therapy, coaching, and wearable sensors for back, knee, hip, and other joint conditions. While US-focused and broader in scope than Orthopy's knee-only focus, it represents the scaled incumbent model of digital orthopedic therapy that Orthopy aspires to in Europe.
  • medi GmbH (orthopedic division): medi is a German medical device manufacturer with significant orthopedic braces, supports, and compression products. As an established German orthopedic medical device incumbent with direct surgeon relationships, medi represents a potential competitive or partnership counterpart to Orthopy in the orthopedic care pathway.

Emerging players

  • Re.flex: Re.flex offers a digital MSK solution combining motion-tracking sensors with a smartphone app for knee and hip rehabilitation. Comparable to Orthopy in targeting knee rehabilitation via mobile app, with a distinguishing motion-sensor hardware component.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Orthopy Health social profiles

Digital presence

Orthopy Health compliance and trust

Trust signal

Compliance5 records

Orthopy Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Orthopy Health leadership team

Management profile

Number of profiles

Profiles7 records

Orthopy Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Orthopy Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orthopy Health

What does Orthopy Health do?

Orthopy Health sells the Orthopy App, a CE-marked Class I medical device mobile application (iOS and Android) that delivers personalized, evidence-based digital therapy accompaniment for patients with knee injuries including ACL ruptures, meniscus damage, and ankle distortions. The app provides individualized training programs with video/audio-guided exercises, prehabilitation modules, patient education content, progress tracking, symptom logging, and interoperable data export for healthcare providers. Patients access the app primarily through the Versorgungsbeobachtung observational study (free), private health insurance reimbursement, or direct self-pay purchase.

Is Orthopy Health a public or private company?

Orthopy Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Orthopy Health founded?

Orthopy Health was founded in 2020. It employs 11 to 50 people.

Where is Orthopy Health based?

Orthopy Health is headquartered in Hamburg, Germany, in the Europe region.

How does Orthopy Health make money?

Three revenue lines are on record. Versorgungsbeobachtung (Observational Study) is the primary driver. The others are private Health Insurance Reimbursement and direct Self-Pay Purchase.

Who are Orthopy Health's main competitors?

Direct peers on record are Kaia Health, Caspar Health, Vivira Health Lab, Selfapy and Sword Health. Broad incumbents are Enovis, Omada Health, Hinge Health and medi GmbH (orthopedic division). Re.flex is listed as an emerging player.

Does Orthopy Health have an API?

No public API is recorded for Orthopy Health.

What industry is Orthopy Health in?

Orthopy Health's product category is Digital Therapeutics — Orthopedic Rehabilitation Software. Its primary akta.pro industry code is HLALAGAO, Orthopedics & Sports Medicine Telemedicine Platforms, with a secondary code of HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up). Its NAICS code is 62134 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales